PROSPECTUS SUPPLEMENT FILED UNDER RULES 424(B)(3) AND (C)
DATED SEPTEMBER 30, 2000 REGISTRATION NO. 333-40714 AND
(TO PROSPECTUS DATED AUGUST 18, 2000) REGISTRATION NO. 333-44294
PROSPECTUS SUPPLEMENT
1,874,160 SHARES
ADATOM.COM, INC.
COMMON STOCK
-------------------
This prospectus supplement supplements the prospectus dated August 18,
2000 relating to the resale by certain securityholders of Adatom.com, Inc. of
common stock of the Company issuable upon conversion of outstanding shares of
the Company's Series A Convertible Preferred Stock ("Preferred Stock") and upon
exercise of outstanding warrants held by the securityholders listed in the
prospectus. The shares reflected above consist of an estimate of the number of
shares which the Company may be required to issue upon conversion of all
unconverted Preferred Stock and upon exercise of all unexercised warrants.
The section of the prospectus entitled "SELLING SECURITYHOLDERS" is
hereby amended by substituting the following table and related footnotes for the
similar information in the prospectus:
---------------
The following table sets forth information as of September 30, 2000
with respect to the selling securityholders and the respective number of shares
of common stock beneficially owned by each selling securityholder. For purposes
of computing the number and percentage of shares beneficially owned by a selling
securityholder on September 30, 2000, any shares which such person has the right
to acquire within 60 days after such date are deemed to be outstanding, but
those shares are not deemed to be outstanding for the purpose of computing the
percentage ownership of any other selling securityholder:
<TABLE>
<CAPTION>
Shares Owned
Shares Being Percent Owned Upon Completion Percent Owned
Name and Address Offered Before Offering Of Offering After Offering
<S> <C> <C> <C> <C>
Alborz Select Opportunities Fund(1) 357,500 2.0% 0 0%
Yasser Moustafa(2) 87,500 .5% 0 0%
Robert DelGuercio(3) 12,500 .07% 0 0%
Pietro Gattini(4) 12,500 .07% 0 0%
Richard Seifert(5) 600,000 3.3% 0 0%
Dr. Victor W. Nee(6) 500,000 2.8% 0 0%
Astor Capital, Inc.(7) 27,500 .15% 0 0%
------------------------
<FN>
(1) Consists of (a) 195,000 common shares issued upon conversion of 195
shares of Preferred Stock based on the aggregate stated value of these
shares of $195,000 divided by an assumed conversion price of $1.00; (b)
warrants to purchase 81,250 shares of our common stock at an exercise
price of $2.295 per share, which are immediately exercisable and expire
on June 22, 2005; and (c) warrants to purchase 81,250 shares of our
common stock at an exercise price of $2.119 per share, which warrants
are immediately exercisable and expire on June 22, 2005. Shares
reported do not include 500 shares of the Company's Series B
Convertible Preferred Stock, or warrants exercisable for 227,270 shares
of common stock, which were acquired by the selling securityholder on
September 27, 2000.
(2) Consists of (a) warrants to purchase 43,750 shares of our common stock
at an exercise price of $2.295 per share, which are immediately
exercisable and expire on June 22, 2005; and (b) warrants to purchase
43,750 shares of our common stock at an exercise price of $2.119 per
share, which warrants are immediately exercisable and expire on June
22, 2005. Shares reported do not include 250 shares of the Company's
Series B Convertible Preferred Stock, or warrants exercisable for
113,36 shares of common stock, which were acquired by the selling
securityholder on September 27, 2000.
<PAGE>
(3) Consists of (a) warrants to purchase 6,250 shares of our common stock
at an exercise price of $2.295 per share, which are immediately
exercisable and expire on June 22, 2005; and (b) warrants to purchase
6,250 shares of our common stock at an exercise price of $2.119 per
share, which warrants are immediately exercisable and expire on June
22, 2005.
(4) Consists of (a) warrants to purchase 6,250 shares of our common stock
at an exercise price of $2.295 per share, which are immediately
exercisable and expire on June 22, 2005; and (b) warrants to purchase
6,250 shares of our common stock at an exercise price of $2.119 per
share, which warrants are immediately exercisable and expire on June
22, 2005. Shares reported do not include 50 shares of the Company's
Series B Convertible Preferred Stock, or warrants exercisable for
22,728 shares of common stock, which were acquired by the selling
securityholder on September 27, 2000.
(5) Consists of a warrant to purchase 600,000 shares of our common stock at
an exercise price of $2.25 per share. The warrant expires on April 4,
2003.
(6) Consists of a warrant to purchase 500,000 shares of our common stock at
an exercise price of $4.375 per share. The warrant expires on March 31,
2004.
(7) Consists of warrants to purchase 27,500 shares of our common stock at
an exercise price of $2.119 per share, which are immediately
exercisable and expire on June 22, 2005 which were issued in partial
payment of the placement agent's fee for the sale of the Preferred
Stock. Shares reported do not include a warrant exercisable for 54,545
shares of common stock, which were acquired by the selling
securityholder on September 27, 2000 which were issued in partial
payment of the placement agent's fee for the sale of the Company's
Series B Convertible Preferred Stock.
</FN>
</TABLE>
2
